To Assess Metabolic Syndrome in Patients of Vitiligo Attending a Tertiary Care Hospital in Central India.

UNLABELLED

Metabolic syndrome has been observed in patients with vitiligo. Literature suggest that there is some link between vitiligo and metabolic syndrome. Autoimmunity, oxidative stress and decreased number of melanocytes are involved in its pathogenesis. This study aimed to assess metabolic syndrome in patients of vitiligo, its association with different types of vitiligo, age of patients and duration of vitiligo.

MATERIAL

We enrolled 62 vitiligo patients who met inclusion criteria in this cross sectional study from 1st august 2020 to 31st July 2021. Detailed history, physical examination and blood investigations were done in all patients and NCEP ATP III criteria was used for diagnosis of metabolic syndrome.

OBSERVATION

Mean age of participants 35.98±15.48 years; M:F:: 1:2.3. Metabolic syndrome was observed in 12.9% vitiligo patients. Advancing age and non segmental vitiligo were significantly associated with metabolic syndrome (p<0.05).

CONCLUSION

Vitiligo is a condition which may affect individual at any age and carries risk of developing metabolic syndrome in future. In our study Metabolic syndrome is observed in 12.9% patients with vitiligo. Early identification of metabolic syndrome and appropriate management of such patients may help in reducing cardiovascular morbidity and mortality. Further prospective studies required to establish relation between vitiligo and metabolic syndrome.